Synthesis, Spectral Characterization and Antitubercular Study of Novel Quinoline Schiff Base and Its Metal Complexes

References

• Dye, C. and Williams, B.G. (2010). The Population dynamics and control of tuberculosis. Science. 328(5980): 856-861.
   PubMed Web of Science ®Google Scholar
• Zumla, A., Nahid, P. and Cole, S.T. (2013). Advances in the development of new tuberculosis drugs and treatment regimens. Nature Review Drug Discovery. 12(50): 388-404.
   PubMedGoogle Scholar
• Zumla, A.I., Gillespie, S.H., Hoelscher, M., Philips, P.P., Cole, S.T., Abubakar, I., McHugh, T.D., Schito, M., Maeurer, M. and Nunn, A.J. (2014). New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Disease. 14(4): 327-340.
   PubMed Web of Science ®Google Scholar
• Global tuberculosis control: WHO report, 2020. Available online: https://www.who.int/tb/publications/global_report/en/. (Accessed on 25 October 2020).
   Google Scholar
• Lugosi, L. (1992). Theoretical and methodological aspects of BCG vaccine from the discovery of calmette and guerin to molecular biology: a review. Tuberculosis Lung Disease. 73(5): 252-261.
   PubMedGoogle Scholar
• Udwadia, Z. ., Amale, R.A., Ajbani, K.K. and Rodrigues, C. (2012). Totally drug-resistant tuberculosis in India. Clinical Infectious Disease. 54: 579-581.
   PubMed Web of Science ®Google Scholar
• Butler, M.S., Blaskovich, M.A. and Cooper, M.A. (2013). Antibiotics in the clinical pipeline in 2013. Journal of Antibiotics (Tokyo). 66(10): 571-591.
   PubMed Web of Science ®Google Scholar
• Diacon, A.H., Donald, P.R., Pym, A., Grobusch, M., Patientia, R.F., Mahanyele, R., Bantubani, N., Narasimooloo, R., De Marez, T. and Heeswijk, R.R. (2012). Andomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: Long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrobial Agents Chemotherapy. 56(6): 3271-3276.
   PubMed Web of Science ®Google Scholar
• Francesca, C., Andreas, H.D., Nosipho, N., Pauline, H., Daniel, E., Angela., Carl, M.M., Erica, E., Joanna, M., Juliano, T., Timothy, D., McHugh. and Genevieve, H.W. (2020). Treatment of highly drug-resistant pulmonary tuberculosis. The New England Journal of Medicine. 382(10): 893-902.
   PubMed Web of Science ®Google Scholar
• Prajapati, I.S. M., Patel, K.D., Vekariya, R.H., Panchal, S.N. and Patel, H.D. (2014). Recent advances in the synthesis of quinolones: a review. RSC Advance. 4: 24463-24476.
   Web of Science ®Google Scholar
• Karad, S.C, Purohit, V.B., Thakor, P., Thakkar, V.R., Raval, D.K. (2016). Novel morpholino-quinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities. European Journal of Medicinal Chemistry. 112: 270-279.
   PubMed Web of Science ®Google Scholar
• Chioua, M., Sucunza, D., Soriano, E., Hadjipavlou-Litina, D., Alcazar, A., Ayuso, I., Oset-Gasque, M.J., Gonzalez, M.P., Monjas, L., Rodriguez-Franco, M.I., Marco-Contelles, J. and Samadi, A. (2012). α-Aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties. Journal of Medicinal Chemistry. 55(1): 153.
   PubMed Web of Science ®Google Scholar
• Singh, K., Kaur, H., Smith, P., Kock, C., Chibale, K. and Balzarini, J. (2014). Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies. Journal of Medicinal Chemistry. 57(2): 435.
   PubMed Web of Science ®Google Scholar
• Nithyanantham, M., Ramaiah, S., Navaneetharaman, A., Vedachalam, G., Joseph, T.L. (2004). Synthesis, Anticonvulsant and Antihypertensive Activities of 8-Substituted Quinoline Derivatives, Biological and Pharmaceutical Bulletin. 27(10): 1683-1687.
   PubMed Web of Science ®Google Scholar
• Tomasic, T., Zidar, N., Rupnik, V., Kovac, A., Blanot, D., Gobec, S., Kikelj, D. and Masic, L.P. (2009). Synthesis and biological evaluation of new glutamic acid-based inhibitors of Mur.D ligase. Bioorganic and Medicinal Chemistry Letters. 19(1): 153-157.
   PubMed Web of Science ®Google Scholar
• Afzal, O., Kumar, S., Haider, Md. R., Ali, Md. R., Kumar, R., Jaggi, M. and Bawa, S.A (2015). Review on anticancer potential of bioactive heterocycle quinoline. European Journal of Medicinal Chemistry. 97: 871-910.
   PubMed Web of Science ®Google Scholar
• Serrao, E., Debnath, B., Otake, H., Kuang, Y., Christ, F., Debyser, Z. and Neamati, N. (2013). Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction. Journal of Medicinal Chemistry. 56(6): 2311-2322.
   PubMed Web of Science ®Google Scholar
• Altenbach, R.J., Liu, H., Banfor, P.N., Browman, K.E., Fox, G.B., Fryer, R.M., Komater, V.A., Krueger, K.M., Marsh, K., Miller, T.R., Pan, J.B., Pan, L., Sun, M., Thiffault, C., Wetter, J., Zhao, C., Zhou, D., Esbenshade, T.A., Hancock, A.A. and Cowart, M.D. (2007). Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists. Journal Medicinal Chemistry. 50(22): 5439-5448.
   PubMed Web of Science ®Google Scholar
• Li, S.N., Xu, Y.Y., Gao, J.Y., Yin, H.R., Zhang, S.L. and Li, H.Q. (2015). Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors. Bioorganic and Medicinal Chemistry Letters. 23(13): 3221-3227.
   Google Scholar
• Nagesh, H.N., Suresh, N., Naidu, K.M., Arun, B., Sridevi, J.P., Sriram, D., Yogeeswari, P. and Chandra Sekhar, K.V.G. (2014). Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. European Journal of Medicinal Chemistry. 74: 333-339.
   PubMed Web of Science ®Google Scholar
• Sangani, C.B., Makawana, J.A., Duan, Y.T., Yin, Y., Teraiya, S.B., Thumar, N.J. and Zhu, H.L. (2014). Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors. Bioorganic and Medicinal Chemistry Letters. 24(18): 4472-4476.
   PubMed Web of Science ®Google Scholar
• Bekhit, A.A., El-Sayed, O.A., Aboulmagd, E. and Park, J.Y. (2004). Tetrazolo [1,5-a] quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents. European Journal of Medicinal Chemistry. 39(3): 249-255.
   PubMed Web of Science ®Google Scholar
• Kategaonkar, A.H., Pokalwar, R.U., Sonar, S.S., Gawali, V.U., Shingate, B.B. and Shingare, M.S. (2010). Synthesis, in vitro antibacterial and antifungal evaluations of new α-hydroxyphosphonate and new α-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline. European Journal of Medicinal Chemistry. 45(3): 1128-1132.
   PubMed Web of Science ®Google Scholar
• Mungra, D.C., Kathrotiya, H.G., Ladani, N.K., Patel, M.P. and Patel, R.G. (2012). Molecular iodine catalyzed synthesis of tetrazolo [1,5-a]-quinoline based imidazoles as a new class of antimicrobial and antituberculosis agents. Chinees Chemical Letter. 23(12): 1367-1370.
   Web of Science ®Google Scholar
• Adhikari, A., Kalluraya, B., Sujith, K.V., Gouthamchandra, K. and Mahmood, R. (2012). Microwave assisted synthesis of novel thiazolidinone analogues as possible bioactive agents. Journal of Advance Research. 3(4): 325-330.
   Google Scholar
• Wang, R., Fan, Y., Dong, T., Su, J. and Huang, X. Du. (2017). Metal(II)-induced synthesis of asymmetric fluorescence benzimidazoles complexes and their dye-sensitized solar 27 cell cerformance as cosensitizers. Crystal Growth Disease. 17(10): 5406-5421.
   Web of Science ®Google Scholar
• Paolucci, G., Zanella, A., Sperni, L., Bertolasi, V., Mazzeo, M. and Pellecchia, C. (2006). Tridentate [N, N, O] Schiff-base group 4 metal complexes: synthesis, structural characterization and reactivity in olefin polymerization. Journal Molecular Catalysis A: Chemical. 258(1-2): 275-283.
   Google Scholar
• Wu, J.Q., Pan, L., Li, Y.G., Liu, S.R. and Li, Y.S. (2009). Synthesis, structural characterization, and olefin polymerization behavior of vanadium (III) complexes bearing tridentate Schiff base ligands. Organometallics. 28(6): 1817-1825.
   Web of Science ®Google Scholar
• Roberts, C.C., Barnett, B.R., Green, D.B. and Fritsch, J.M. (2012). Synthesis and structures of tridentate ketoiminate zinc complexes that act as l-lactide ring-opening polymerization catalysts. Organometallics. 31(11): 4133-4141.
   Web of Science ®Google Scholar
• Mistry, B.M., Sahoo, S.K. and Jauhari, S. (2013). Experimental and theoretical investigation of 2-mercaptoquinoline-3-carbaldehyde and its Schiff base as an inhibitor of mild steel in 1 M HCl. Journal of Electroanalytical Chemistry. 704: 118-129.
   Web of Science ®Google Scholar
• Liu, Z.C., Wang, B.D., Li, B., Wang, Q., Yang, Z.Y. and Li, T.R. (2010). Crystal structures, DNA-binding and cytotoxic activities studies of Cu (II) complexes with 2-oxo-quinoline-3-carbaldehyde Schiff-bases. European Journal of Medicinal Chemistry. 45(11): 5353-5361.
   PubMed Web of Science ®Google Scholar
• Sadeek, S., El Attar, M. and El Hamid, S.A. (2013). Preparation and characterization of new tetradentate Schiff base metal complexes and biological activity evaluation. Journal of Molecular Structure. 1051: 30-40.
   Web of Science ®Google Scholar
• Vivekanand, B., Raj, K.M. and Mruthyunjayaswamy, B.H.M. (2015). Synthesis, characterization, antimicrobial, DNA-cleavage and antioxidant activities of 3-((5-chloro-2-phenyl-1H-indol3-ylimino) methyl) quinoline-2 (1H)-thione and its metal complexes. Journal of Molecular Structure. 1079: 214-224.
   Web of Science ®Google Scholar
• Adsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q.P. and Padhye, S. (2006). Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells. Journal of Medicinal Chemistry. 49(24): 7242-7246.
   PubMed Web of Science ®Google Scholar
• Alexpandi, R., De Mesquita, J.F., Pandian, S.K. and Ravi, A.V. (2020). Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis. Frontiers in Microbiology. 11: 1796-1809.
   PubMed Web of Science ®Google Scholar
• Singh, R.M. and Srivastava, A. (2005). Vilsmeier-Haack reagent: A facile synthesis of 2-chloro-3-formylquinolines from N-arylacetamides and transformation into different functionalities. Indian Journal of Chemistry. 44: 1868-1880.
   Google Scholar
• Hartkoorn, R.C., Chandler, B., Owen, A., Ward, S.A., Squire, S.B., Back, D.J. and Khoo, S.H. (2007). Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. Tuberculosis. 87(3): 248-255.
   PubMed Web of Science ®Google Scholar
• Ali, I. and Wani, W. (2012). Empirical formulae to molecular structures of metal complexes by molar conductance. Synthesis and reactivity in inorganic, metal-organic, and nano-metal chemistry. 43(10): 1080.
   Google Scholar
• Neslihan, B., Didem, Ç. and Cahit, D. (2017). Chromone-based Schiff base metal complexes as catalysts for catechol oxidation: Synthesis, kinetics and electrochemical studies. Tetrahedron. 73(19): 256-275
   Web of Science ®Google Scholar
• Rateek, T., Sulekh, C. and Saraswat, B.S. (2015). Ni(II) and Zn(II) complexes of 2-((thiophen-2-ylmethylene)amino)benzamide: Synthesis, spectroscopic characterization, thermal, DFT and anticancer activities. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 134C: 200-209.
   Google Scholar
• Singh, D.P., Kumar, R., Malik, V. and Tyagi, P. (2007). Synthesis and characterization of complexes of Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) with macrocycle 3,4,11,12-tetraoxo-1,2,5,6,9,10,13,14-octaaza-cyclohexadeca-6,8,14,16-tetraene and their biological screening. Transition Metal Chemistry. 32(8): 1051-1055.
   Web of Science ®Google Scholar
• Rao, T.R. and Prasad, A. (2005). Syntheis and spectral studies on 3d metal complexes of mesogenic Schiff base ligands. Part 1. Complexes of N-(4-butylphenyl) salicylaldimine. Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry. 35(4): 299-304.
   Web of Science ®Google Scholar
• Greenwood, N.N. and Earnshaw, A. (1997). Chemistry of the elements. Heimemann, Oxford, UK 2nd edition.
   Google Scholar
• Balasubramanian, S. and Krishnan, C.N. (1986). Syntheis and characterization of five-coordinatinate macrocyclic complexes of nickel(II) and copper(II). Polyhedron. 5(3): 669-675.
   Web of Science ®Google Scholar
• Thaker, B.T., Tandel, P.K., Patel, A.S., Vyas, C.J., Jesani M.S. and Patel, D.M. (2005). Synthesis and mesomorphic characterization of Cu(II), Ni(II) and Pd(II) complexes with azomethine and chalcone as bridging group. Indian Journal of Chemistry A. 44(2): 265-270.
   Google Scholar
• Kivelson, D. (1997). Publications of daniel kivelson. Journal of Physical Chemistry B. 101(43): 8631-8634.
   Web of Science ®Google Scholar
• Iona, E., Pardini, M., Gagliardi, M.C., Colone, M., Stringaro, A.R., Teloni, R., Brunori, L., Nisini, R., Fattorini, L. and Giannoni, F. (2012). Infection of human THP-1 cells with dormant Mycobacterium tuberculosis. Microbes Infection. 14: 959-967.
   PubMed Web of Science ®Google Scholar
• Mandewale and Mustapha. (2015). Synthesis and anti-mycobacterium study of some fluorine containing schiff bases of quinoline and their metal complexes. Der Pharma Chemica. 7: 207-215
   Google Scholar
• Mustapha, C., Mandewale, B.T., Dyaneshwar, S. and Ramesh, Y. (2015). Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu(II) and Zn(II) complexes against mycobacterium tuberculosis. Bioinorganic Chemistry and Applications. 2015: 1-14.
   Web of Science ®Google Scholar
• Pardini, I.E., Gagliardi, M., Colone, M.C., Stringaro, M., Teloni, A.R., Brunori, R., Nisini, L., Fattorini, R. and Giannoni, L.F. (2012). Infection of human THP-1 cells with dormant Mycobacterium tuberculosis. Microbes Infection. 14: 959-1102.
   PubMed Web of Science ®Google Scholar